Valacyclovir and acyclovir are the same active drug delivered in different ways. Valacyclovir is a “prodrug,” meaning your body converts it into acyclovir after you swallow it. The practical difference comes down to how well each one is absorbed and how often you need to take it. Valacyclovir reaches about 55% oral bioavailability, three to five times higher than acyclovir alone, which means fewer pills per day for the same therapeutic effect.
How Valacyclovir Becomes Acyclovir
Valacyclovir is acyclovir with an amino acid (L-valine) attached to it. That small chemical addition makes the drug much easier for your intestines to absorb. Once it enters your body, an enzyme rapidly strips off the valine, leaving behind plain acyclovir plus a harmless amino acid. This conversion happens so quickly during its first pass through the gut and liver that the drug circulating in your blood is essentially acyclovir.
Because both drugs deliver the same active molecule, they work the same way once they reach infected cells. The active drug blocks the virus’s ability to copy its DNA, slowing down replication and giving your immune system time to control the outbreak.
Dosing Frequency Is the Biggest Practical Difference
The higher absorption of valacyclovir translates directly into fewer daily doses. For a first genital herpes outbreak, valacyclovir is typically taken twice a day for 10 days. Acyclovir for the same situation requires dosing five times a day, which many people find difficult to maintain on a normal schedule.
For shingles, valacyclovir is taken three times daily compared to acyclovir’s five-times-daily regimen. Recurrent genital herpes episodes call for valacyclovir twice a day for three days. And for long-term suppressive therapy to prevent outbreaks, valacyclovir can be taken just once daily.
Fewer doses means it’s easier to stay on schedule. Missing doses of an antiviral reduces its effectiveness, so the simpler regimen is a genuine clinical advantage, not just a convenience.
Effectiveness for Shingles
A large clinical trial of over 1,100 patients aged 50 and older compared the two drugs head-to-head for shingles. Skin healing progressed at similar rates in both groups, but valacyclovir resolved pain faster. Patients on a 7-day course of valacyclovir had a median pain duration of 38 days, compared to 51 days for those on acyclovir. Valacyclovir also reduced the risk of lingering nerve pain (postherpetic neuralgia) that can persist for months: 19.3% of valacyclovir patients still had pain at six months versus 25.7% on acyclovir.
Researchers attributed this advantage largely to the higher and more consistent blood levels valacyclovir achieves, thanks to its better absorption. Both drugs had similar safety profiles in the trial.
Suppressive Therapy and Viral Shedding
For people who take daily medication to prevent genital herpes outbreaks and reduce the risk of transmitting the virus to a partner, valacyclovir is the more commonly prescribed option. Its once-daily dosing makes long-term use more manageable.
Research on suppressive valacyclovir therapy has shown a 94% reduction in detectable viral shedding, the process by which the virus reaches the skin surface even when no sores are present. Less shedding means a lower chance of passing the infection to someone else, which is one of the main reasons people choose suppressive therapy in the first place.
Side Effects and Kidney Considerations
Because valacyclovir converts into acyclovir, the side effect profiles are nearly identical. The most common issues are headache, nausea, and abdominal discomfort. Both drugs are cleared through the kidneys, and both require dose adjustments for people with reduced kidney function.
For valacyclovir, dose reductions begin when kidney filtration drops below 50 mL/min, with progressively lower or less frequent doses as kidney function declines further. Staying well hydrated while taking either medication helps protect the kidneys. People on dialysis can still use valacyclovir but need to time their dose after sessions, since about one-third of the active drug is removed during a four-hour dialysis treatment.
Use in Children
Acyclovir has long been available as a liquid suspension, making it the traditional choice for young children who can’t swallow pills. Valacyclovir does not come as a commercial liquid, though pharmacists can prepare an oral suspension by crushing tablets and mixing them with a structured vehicle. The FDA has reviewed pharmacokinetic studies of this compounded suspension in children as young as one month old.
In pediatric studies, valacyclovir suspension produced acyclovir blood levels comparable to or higher than those achieved with standard acyclovir suspension dosing in children. However, acyclovir suspension remains more widely stocked and familiar to most pharmacies, so it is still the default for many pediatric prescriptions.
Safety During Pregnancy
Both drugs are used during pregnancy. Acyclovir has the longer safety track record, with many years of exposure data showing no increased risk across all trimesters. The CDC recommends starting suppressive therapy at 36 weeks of pregnancy to reduce the chance of an active outbreak at delivery, which could otherwise require a cesarean section. Either acyclovir (taken three times daily) or valacyclovir (taken twice daily) is considered appropriate for this purpose.
Animal studies suggest valacyclovir carries a similarly low risk, but human exposure data is more limited. In practice, many clinicians now prescribe valacyclovir during pregnancy because the simpler dosing improves adherence during a period when taking medication on schedule genuinely matters.
Cost Differences
Generic acyclovir is one of the least expensive antiviral medications available, with retail prices around $19 for a course without insurance. Generic valacyclovir costs more than acyclovir but significantly less than the brand-name version, Valtrex. The price gap has narrowed considerably since valacyclovir went generic, and most insurance plans and discount programs cover both. For people paying out of pocket, acyclovir’s lower price can be meaningful, especially for long-term suppressive therapy where the cost compounds month after month.
Which One Is Right for You
If effectiveness is the priority, valacyclovir has a slight edge for shingles pain resolution and offers the same antiviral activity with better absorption. If cost matters and you can manage a five-times-daily schedule, acyclovir works just as well at killing the virus. For long-term suppressive therapy, valacyclovir’s once-daily dosing makes it the more practical choice. For young children, acyclovir’s ready-made liquid form gives it an advantage. And for pregnant patients, both are considered safe, with the choice often coming down to how many daily doses feel manageable during the final weeks before delivery.